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First isolation of West Nile virus from a dromedary camel
Sunitha Joseph1, Ulrich Wernery1, Jade LL Teng2, Renate Wernery1, Yi Huang2, Nissy AG Patteril1,
Kwok-Hung Chan2, Shyna K Elizabeth1, Rachel YY Fan2, Susanna KP Lau2,3,4,5,6, Jörg Kinne1 and
Patrick CY Woo2,3,4,5,6
Although antibodies against West Nile virus (WNV) have been detected in the sera of dromedaries in the Middle East, North
Africa and Spain, no WNV has been isolated or ampliﬁed from dromedary or Bactrian camels. In this study, WNV was isolated
from Vero cells inoculated with both nasal swab and pooled trachea/lung samples from a dromedary calf in Dubai. Complete-
genome sequencing and phylogenetic analysis using the near-whole-genome polyprotein revealed that the virus belonged to
lineage 1a. There was no clustering of the present WNV with other WNVs isolated in other parts of the Middle East. Within
lineage 1a, the dromedary WNV occupied a unique position, although it was most closely related to other WNVs of cluster 2.
Comparative analysis revealed that the putative E protein encoded by the genome possessed the original WNV E protein
glycosylation motif NYS at E154–156, which contained the N-linked glycosylation site at N-154 associated with increased WNV
pathogenicity and neuroinvasiveness. In the putative NS1 protein, the A70S substitution observed in other cluster 2 WNVs and
P250, which has been implicated in neuroinvasiveness, were present. In addition, the foo motif in the putative NS2A protein,
which has been implicated in neuroinvasiveness, was detected. Notably, the amino-acid residues at 14 positions in the present
dromedary WNV genome differed from those in most of the closely related WNV strains in cluster 2 of lineage 1a, with the
majority of these differences observed in the putative E and NS5 proteins. The present study is the ﬁrst to demonstrate the
isolation of WNV from dromedaries. This ﬁnding expands the possible reservoirs of WNV and sources of WNV infection.
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INTRODUCTION
West Nile virus (WNV) is a positive-sense single-stranded ribonucleic
acid (RNA) virus in the Flaviviridae family. WNV is the leading cause
of mosquito-borne encephalitis in humans in many parts of the world.
In addition to humans, many animals are also susceptible to WNV
infections. Large outbreaks have occurred globally in both humans
and other animals, such as horses and pigs. Birds are the natural
reservoirs of WNV. Bird-to-bird, bird-to-mammal and bird-to-human
transmissions are achieved by mosquito bites, with humans and other
mammals serving as dead-end hosts because of low viral loads.
Camels are one of the most unique mammals on earth and have
shown perfect adaptation to desert life. There are two surviving
old-world camel species: Camelus dromedarius (dromedary or one-
humped camel), which inhabits the Middle East and North and
Northeast Africa, and Camelus bactrianus (Bactrian or two-humped
camel), which inhabits Central Asia. Among the 20 million camels on
earth, 90% are dromedaries. Although WNV is known to infect some
of the new world camels, such as llamas and alpacas,1 only antibodies
against WNV have been detected in the sera of old-world camels,
such as the dromedaries in the Middle East, North Africa and Spain,
with a seroprevalence of 3%–38%.2–5 To date, no WNV has been
isolated or ampliﬁed from either dromedary or Bactrian camels.
Recently, the emergence of Middle East respiratory syndrome (MERS)
and the isolation of the MERS coronavirus (MERS-CoV) from
dromedaries boosted interest in the search for novel viruses in
dromedaries.6–13 In this article, we report the ﬁrst isolation of WNV
from a dromedary calf in the United Arab Emirates during the process
of MERS-CoV screening and the results of the comparative genome
and phylogenetic analysis.
MATERIALS AND METHODS
Sample collection and viral culture
Clinical samples were obtained during a necropsy of a dromedary calf
at the Central Veterinary Research Laboratory in Dubai, the United
Arab Emirates, using standard procedures. The Central Veterinary
Research Laboratory in Dubai is the center for performing necropsies
of dromedaries from sheikhs in the UAE with the aim of ﬁnding the
cause of death and preventing the spread of infectious diseases to other
camels or herds. Nasal swabs and pooled ground trachea/lung samples
were inoculated onto Vero cells for MERS-CoV screening.14 The
pooled clinical samples were diluted 10-fold with viral transport medium
and ﬁltered. Two hundred microliters of the ﬁltrate was inoculated into
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200 μL of minimum essential medium (Gibco, Grand Island, NY, USA).
Four hundred microliters of the mixture was added to 24-well tissue
culture plates with Vero cells by adsorption inoculation. After 1 h of
adsorption, the excess inoculum was discarded, the wells were washed
twice with phosphate-buffered saline, and the medium was replaced with
1mL of minimum essential medium (Gibco). Cultures were incubated at
37 °C with 5% CO2 and inspected for cytopathic effects daily using
inverted microscopy.
Electron microscopy
Negative-contrast electron microscopy was performed as previously
described.15 Tissue culture cell extracts infected with dromedary WNV
were centrifuged at 19 000g at 4 °C. Then, the pellet was resuspended
in phosphate-buffered saline and stained with 2% phosphotungstic
acid. Samples were examined with a Philips EM208s electron
microscope (Philips Scientiﬁcs, Eindhoven, The Netherlands).
Sample preparation for Illumina sequencing
RNA was extracted from the isolated virus using the QIAamp Viral
RNA Mini Kit (Qiagen, Hilden, Germany). Reverse transcription and
polymerase chain reaction (PCR) were performed using the Super-
Script III reverse transcriptase (Invitrogen, Carlsbad, CA, USA) and a
random primer containing a 20-base arbitrary sequence at the 5′ end
followed by a randomized octamer (8N) at the 3′ end. A single round
of priming and extension was performed using the Klenow fragment
polymerase (New England Biolabs, Ipswich, UK). PCR ampliﬁcation
with a primer consisting of only the 20-base arbitrary sequence of the
random primer was performed with 20 cycles of 94 °C for 15 s, 60 °C
for 30 s and 68 °C for 1 min and a ﬁnal extension at 68 °C for 7 min in
an automated thermal cycler (Applied Biosystems, Carlsbad, CA,
USA). Standard precautions were taken to avoid PCR contamination,
and no ampliﬁed PCR product was observed in the negative control.
The PCR product was puriﬁed using the MinElute PCR Puriﬁcation
Kit (Qiagen) following the manufacturer’s protocol. The puriﬁed DNA
was eluted in 15 μL of EB buffer and used as the template for library
construction.16
Library construction for Illumina sequencing
The metagenomics library was generated using a DNA library prepared
with the Nextera XT DNA sample preparation Kit (Illumina,
San Diego, CA, USA) according to the manufacturer’s protocol.
Brieﬂy, 1 ng of input DNA was tagmented by the Nextera XT
transposome at 55 °C for 5 min. This transposome simultaneously
fragmented the input DNA and added an adapter sequence to the ends,
thereby allowing ampliﬁcation by PCR in subsequent steps. The
sequencing library with the tagmented DNA was ampliﬁed in 12
cycles of 95 °C for 10 s, 55 °C for 30 s and 72 °C for 30 s and a ﬁnal
extension at 72 °C for 5 min in an automated thermal cycler (Applied
Biosystems). The ampliﬁed DNA library was puriﬁed using
1.8×AMPure XP beads (Beckman Coulter, Indianapolis, IN, USA)
to remove very short library fragments from the population. The
ampliﬁed DNA library was analyzed using the 2100 Bioanalyzer
instrument (Agilent Technologies, Santa Clara, CA, USA). The puriﬁed
sequencing library was quantiﬁed using the KAPA library quantiﬁca-
tion kit (Kapa Biosystems, Wilmington, DE, USA) and subsequently
sequenced on the Illumina HiSeq 2500 with 151 bp paired-end reads
(Rapid Run Mode). Image analysis and base calling were performed
with SCS2.8/RTA1.8 (Illumina). FASTQ ﬁle generation and the
removal of failed reads were performed using CASAVA ver.1.8.2
(Illumina).16
Genome assembly and complete-genome sequencing
Illumina sequence reads were quality trimmed by Prinseq-lite, and
de novo genome assembly was performed with MIRA 4.9. The 5′ and
30 ends of the viral genome were conﬁrmed by rapid ampliﬁcation
of cDNA ends (RACE) using the 5′/3′ RACE kit (Roche, Penzberg,
Germany).
Comparative genome analysis and phylogenetic analysis
The nucleotide sequence of the genome and the deduced amino-acid
sequences of the open reading frames were compared with those of
other WNV strains with complete genomes in the ViPR sequence
database (http://www.viprbrc.org/). N-linked glycosylation sites were
predicted using the NetNGlyc 1.0 software (http://www.cbs.dtu.dk/
services/NetNGlyc/). Complete polyprotein nucleotide sequences were
aligned with MUSCLE. A maximum-likelihood phylogenetic tree with
1000 bootstraps was constructed using the GTR substitution model;
gamma distribution among sites was conducted in MEGA5.
Figure 1 (A) Cytopathic effects of WNV from a dromedary on Vero cells,
showing cell rounding, degeneration and detachment, magniﬁcation: ×40.
(B) Negative contrast electron microscopic examination of an infected Vero cell
culture supernatant showing enveloped icosahedral viral particles, bar=100 nm.
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Nucleotide sequence accession numbers
The nucleotide sequence of the dromedary WNV genome isolated in
this study has been lodged in the GenBank sequence database under
accession NO KU588135.
RESULTS
Necropsy, virus culture and electron microscopy
Necropsy of the female 1-month-old 50 kg fresh dromedary calf revealed
pale muscles and myocard, massive lung congestion and colitis. The
causes of death were white muscle disease, colisepticemia and Candida
enteritis. At the ﬁrst passage, the Vero cells inoculated with both the nasal
swab and pooled trachea/lung samples showed identical cytopathic effects
on day 4, with cell rounding, progressive degeneration and detachment
(Figure 1A). Electron microscopy showed enveloped icosahedral virions
45–50 nm in diameter with a 25- to 35-nm electron dense core
(Figure 1B). Both the cytopathic effects and viral morphology were
inconsistent with those of MERS-CoV.
Complete-genome sequencing and genome structure
The complete genome of the isolated virus was sequenced and
assembled. The size, G+C content and genome structure were similar
to other WNVs. The single polyprotein is putatively cleaved by
proteases into three structural proteins (capsid (C), premembrane/
membrane (prM/M) and envelope (E)) and seven nonstructural
proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5).
Phylogenetic analysis
Phylogenetic analysis using the near-whole-genome polyprotein
revealed that the virus belonged to lineage 1a (Figure 2A).17 The
present dromedary WNV occupied a unique position within lineage
1a, although it was most closely related to other WNVs of cluster 2
(Figure 2B).
Comparative genome analysis
Comparative analysis based on the complete polyprotein sequence
showed the highest (99.51%–99.56%) overall amino-acid identities to
WNV strains isolated from a mosquito in Kenya (Genbank accession
number AY262283), horses in Italy and Morocco (Genbank accession
numbers AF404757, AY701413 and AY701412) and a human in Italy
(Genbank accession number JQ928175). Detailed annotation revealed
that the putative E protein encoded by the genome possessed the
original WNV E protein glycosylation motif NYS at E154–156, which
contained the N-linked glycosylation site at N-154 associated with
increased WNV pathogenicity and neuroinvasiveness.18 In the putative
NS1 protein, the A70S substitution observed in other cluster 2 WNVs
and P250, which was implicated in neuroinvasiveness, were also
present.19 In addition, the foo (ﬂavivirus overlapping ORF) motif in
the putative NS2A protein that was implicated in neuroinvasiveness
was detected.20 Notably, 14 amino-acid residues in the present
dromedary WNV genome differed from those in most of the closely
related WNV strains in cluster 2 of lineage 1a (Figure 3), with the
majority of these differences observed in the putative E and NS5
proteins.
DISCUSSION
We report the ﬁrst isolation of WNV in a dromedary. The ﬁrst
evidence for the presence of hemagglutination inhibiting and
complement-ﬁxing antibodies in dromedaries from Nigeria against
WNV was published in 1990.21,22 Recently, a study has shown the
presence of neutralizing antibodies against WNV from dromedaries in
North Africa.3 In the United Arab Emirates, antibodies against WNV
have been reported in 38% of 1119 dromedary sera5 and 19.2% of 750
tested equine sera,23 supporting the conclusion that WNV is present in
the country. In the present study, we isolated a WNV from two
independent respiratory samples from a dromedary calf using Vero
cells, which is one of the most widely used cell lines for the recovery of
WNV. This ﬁnding was consistent with previous studies that showed
that WNV could also be detected in respiratory specimens from birds,
humans and other mammals.24,25 Notably, the glycosylation motif
NYS in the E protein, the A70S substitution and P250 in the NS1
protein and the foo motif in the NS2A protein, which are important
for pathogenicity and neuroinvasiveness, were also detected in
the present WNV isolate.18–20 However, because there were no clinical
signs in the dromedary calf, the pathogenic role of WNV in
dromedaries remains to be determined. Viral cultures using other
samples from the dromedary were not performed because the samples
were initially intended for MERS-CoV isolation.
The present dromedary WNV belongs to WNV lineage 1a. The
whole-genome phylogenetic trees showed that the present dromedary
WNV was most closely related to other WNVs in cluster 2 of lineage
1a with high bootstrap support (Figure 2). However, there was no
clustering of the present WNV with WNVs isolated in other parts
of the Middle East, such as Israel, Egypt and Cyprus (data not shown).
Indeed, two WNVs from Israel (Genbank accession number AY688948)
and Cyprus (Genbank accession number GQ903680) belong to
lineage 2, another isolate from Israel (Genbank accession number
HM152773) belongs to cluster 4 of lineage 1a, and two other isolates
from Israel (Genbank accession number HM051416) and Egypt
(Genbank accession number EU081844) belong to cluster 1 of lineage
1a. Moreover, 14 amino-acid positions located in various regions of the
genome encoding ﬁve different proteins showed marked differences
with the corresponding amino acids in the genomes of the isolate’s
close relatives in cluster 2. Interestingly, most of the amino-acid
differences between the present dromedary WNV and the closely
related WNVs from Africa and Europe are located in the E and NS5
genes. The E protein is generally the least conserved protein because it
is exposed to external selection pressure, whereas the NS5 protein is
highly conserved because it contains the viral methyltransferase and
RNA-dependent RNA polymerase. Complete-genome sequencing of
more WNV strains and comparative genomic and phylogenetic studies
are needed to ascertain whether dromedary WNVs form a unique
cluster in lineage 1a.
The MERS epidemic and the discovery of dromedaries as the
reservoir of MERS-CoV have boosted interest in the search for
novel viruses in dromedaries. Prior to 2013, viruses from at least
eight families were found to infect camels. In the last two years, we
have reported the discovery of a novel dromedary camel CoV (UAE-
HKU23), a novel genotype of hepatitis E virus, a novel genus of
enterovirus, a novel astrovirus, and novel picobirnaviruses and
circoviruses in dromedaries.16,26–29 These discoveries have remarkably
widened the spectrum of viruses known to infect dromedaries.
Notably, after the description of the novel genotype of hepatitis
E virus in dromedaries, another group found this dromedary camel
hepatitis E virus as a cause of chronic hepatitis E infection in a liver
transplant recipient with a habit of camel milk and meat consumption,
highlighting the importance of camels as a source of infectious
diseases.30 The present study is the ﬁrst demonstration of the isolation
of WNV in dromedaries and the ﬁrst WNV complete-genome
sequenced from a dromedary among the relatively few full-length
WNV genome sequences from the Middle East. Further studies will
help elucidate whether dromedaries can serve as another possible
source of WNV infection and determine the tissue tropism of WNV in
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Figure 2 Phylogenetic tree showing the relationship of dromedary WNV to other WNV strains based on a complete polyprotein sequence by the
maximum-likelihood method in MEGA5. (A) WNV strains of all lineages and clusters are indicated except for those of lineages 4b, 5 and 7
because no complete polyprotein sequence is available from these lineages. A total of 10 345 nucleotide positions were included in the analysis.
Japanese encephalitis virus strain Nakayama (EF571853) was used as the outgroup. (B) WNV strains of cluster 2 that are most related to the
dromedary WNV and strains of the other clusters within lineage 1a are indicated. A total of 10 302 nucleotide positions were included in the
analysis. Kunjin strain MRM61C (D00246) of lineage 1b was used as the outgroup. The scale bar indicates the number of nucleotide
substitutions per site. All names and accession numbers are given as cited in the ViPR sequence and GenBank databases. Bootstrap values are
shown only for nodes that were well supported by the maximum-likelihood method (⩾700 bootstrap support).
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dromedaries. Other studies on the epidemiology, disease spectrum and
ecology of WNV in this group of unique animals are also warranted.
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